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1. It was the aim of the present study to find out if a common mechanism exists by which the vasoconstrictive
hormones angiotension II, noradrenaline and 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (AGEPC)
increase prostaglandin E2 (PGE2) synthesis in cultures of rat renal mesangial cells. 2. Angiotension II,
noradrenaline and AGEPC stimulated PGE2 synthesis and uptake of45Ca2+ in cultured mesangial cells. Both
of these effects could be completely suppressed by the calcium channel blocker verapamil. 3. Angiotensin
II, noradrenaline and AGEPC caused a rapid breakdown of phosphatidylinositol 4,5-bisphosphate with a
concomitant increase of 1,,2-diacylglycerol and inositol trisphosphate, indicating an activation of phospho-
lipase C by these hormones. Addition of verapamil had no effect on the hormone-induced stimulation of
phospholipase C. 4. The synthetic analogue of diacylglycerol, l -oleoyl-2-acetylglycerol, and the phorbol ester
12-O-tetradecanoylphorbol 13-acetate (TPA), both of which are known to stimulate protein kinase C,
enhanced PGE2 synthesis. Chelation of extracellular calcium with EDTA or addition of verapamil abolished
the effect of 1 -oleoyl-2-acetylglycerol and phorbol ester on PGE2 synthesis. 5. 1-Oleoyl-2-acetylglycerol and
phorbol ester increased the uptake of 45Ca2+ by the cells in a dose-dependent manner and this effect could
be blocked by verapamil. 6. The entirety of these data leads us to suggest that vasoconstrictor-evoked
synthesis of PGE2 in rat mesangial cells is mediated by the subsequent activation of phospholipase C and
protein kinase C. The activation of protein kinase C by diacylglycerol is likely to be involved in the increase
of the calcium permeability of the plasma membrane which is a prerequisite for PGE2 synthesis induced by
vasoconstrictive hormones.
INTRODUCTION
Angiotensin II and AVP are thought to affect the
filtration function of renal glomeruli by causing a
contraction of glomerular mesangial cells (Mahieu et al.,
1980; Ausiello et al., 1980; Scharschmidt & Dunn, 1983;
Fujiwara et al., 1984). Furthermore, angiotension II and
AVP enhance the synthesis of vasodilatatory prosta-
glandins by mesangial cells which supposedly modulate
the contractile effect of angiotension II and AVP
(Kreisberg et al., 1982; Scharschmidt & Dunn, 1983).
Scharschmidt & Dunn (1983) have shown that the
stimulation ofPG synthesis by angiotension II and AVP
in cultured renal mesangial cells strongly depends on the
availability of extracellular calcium, because calcium
channel blockers or the omission of extracellular
calcium abolished the peptide-stimulated PG production.
It is generally agreed upon that hormones that mediate
physiological responses through calcium mobilization
also stimulate the metabolism of membrane phospho-
inositides, i.e. the PI cycle (cf. Michell et al., 1981;
Michell, 1982). Recently we have shown that one of the
early events in the stimulation of PG synthesis by AVP
in cultured renal mesangial cells is an activation of
phospholipase C as evaluated by the rapid breakdown of
PIP2 and the appearance of DG and phosphatidic acid
(Pfeilschifter et al., 1984). However, it is not clear in what
way the requirement for extracellular calcium in
prostaglandin production and the activation of phospho-
lipase C in the vasoconstrictor-induced synthesis of PG
are inter-related. The present study was carried out in
order to gain some insights into the nature of the link
between an activation of phospholipase C by vasocon-
strictive hormones in cultured rat renal mesangial cells
and the recruitment of extracellular calcium. Experi-
mental evidence indicates that an activation of protein
kinase C byDG enhances the calcium permeability of the
plasma membrane which is conditional for the vasocon-
strictor-induced stimulation of PGE2 synthesis.
Part of this material was presented in abstract form at
the 61st meeting of the German Physiological Society
(Pfeilschifter et al., 1985).
EXPERIMENTAL PROCEDURES
Cell culture
The preparation of isolated glomeruli from rat kidneys
and subculture of glomerular outgrowths was done as
described (Kurtz et al., 1982, 1983). In brief, glomeruli
from male Sprague-Dawley rats (70-100 g body wt.)
were prepared under sterile conditions. The kidneys were
first flushed free of blood. Renal cortical tissue was
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removed and consecutively passed through polyamide
screens (Verseidag, Kempen, Germany) with pore sizes of
100 lsm and 180 ,um onto a screen of 50 ,um pore size.
Preparations of glomeruli from the 50 ,m screen were
seeded in 75cm2 tissue flasks (Greiner, Niirtingen,
Germany). Glomerular cell outgrowths subcultured 3
weeks after the first inoculation were used for all
experiments. Subcultures obtained from day 21 derive
from mesangial cells (Foidart et al., 1979; Kurtz et al.,
1983). The cells were grown in RPMI 1640 (Boehringer,
Mannheim, Germany) supplemented with 10% fetal
bovine serum (Boehringer), penicillin at 100 units/ml,
streptomycin at 100 ,ug/ml (Boehringer) and bovine
insulin at 0.66 units/ml (Sigma). Tissue flasks and dishes
were kept at 37 °C in a humidified atmosphere in
incubators in air/CO2 (19:1).
45Ca2+ uptake
The culture medium was substituted by prewarmed
HBS consisting of 20 mM-Hepes, 148 mM-NaCl,
5 mM-KCl, 2 mM-CaCl2, 1 mM-MgCl2, 6 mM-glucose,
pH 7.35, supplemented with 45Ca2+ (4 ,uCi/ml) and the
culture dishes were placed on a heater to maintain a
temperature of 37 'C. Verapamil was added where
indicated at a final concentration of 10-5 M 5 min prior
to the addition of the agonists. The vasoconstrictive
agents were dissolved either separately or in combination
with verapamil in HBS containing 45Ca2+. OAG stock
solution in dimethyl sulphoxide was diluted to 1%
dimethyl sulphoxide with HBS containing 0.3 mg of
bovine serum albumin (fatty acid free)/ml. This OAG
solution was then briefly sonicated under N2 before
addition to the cells. The final dimethyl sulphoxide
concentration was < 0.1 %. Controls were done with
HBS containing the solvent only. At 15 s, 30 s, 60 s and
120 s after the addition of the agonists, buffer was
withdrawn and the cells were quickly washed with
10 x 1 ml of ice-cold HBS containing 10 mM-CaCl2. The
high Ca2+ concentration (10 mM) was chosen in order to
diminish Ca2+ effilux from the cells. The cells were lysed by
the addition of2 ml of0.5 M-NaOH and the radioactivity,
which represents the amount of intracellular 45Ca2 , was
counted in Aquasol 2 (New England Nuclear) in a
,8-scintillation counter. An aliquot was taken for protein
determination. The influx of Ca2+ was determined from
the initial rate of 45Ca2+ uptake by the cells. This initial
rate of 45Ca2+ uptake was linear over the 120 s periods
of measurement as estimated from linear-regression
analysis.
Cell labelling
Medium was removed and the cells were incubated in
MEM (Boehringer) supplemented with fatty acid-free
bovine serum albumin (0.3 mg/ml) (Sigma) and
[14C]arachidonic acid (0.25 j#Ci/ml) for 24 h. For the
determination of phosphoinositides, cells were labelled
with carrier-free 32P1 (100,uCi/ml) in phosphate-poor
MEM (50 gM-Pi) containing 10% dialysed fetal bovine
serum for 24 h. For the determination of the inositol
phosphates, cells were prelabelled for 72 h with myo-
[2-3H]inositol (10 ,uCi/ml) in MEM free of inositol,
containing 10% dialysed fetal bovine serum.
Lipid extraction and separation
After the prelabelling period the medium was replaced
by fresh medium either with or without agonists.
Incubations were terminated by rapid withdrawal of
incubation medium and the addition of I ml of ice-cold
methanol to the cells. The lipid extraction was done
according to Bligh & Dyer (1959) with a final proportion
of 2 ml of methanol, 2 ml of chloroform and 1.6 ml of
water (containing 0.74% KCI, 0.04% CaCl2 and 0.034%o
MgCl2). After removal of the first chloroform extract, the
remaining methanol/water phase was acidified with HCI
(final concentration 0.01 M) and extracted twice with 2 ml
of chloroform. The chloroform extracts were combined
and dried in a rotation evaporator, dissolved in 200 #1 of
chloroform/methanol (2:1, v/v) and an aliquot was
taken for t.l.c. Thin layer plates (pre-coated silica gel 60
with concentration zone, 0.25 mm thick) from Merck,
Darmstadt, Germany were used throughout all experi-
ments. Separation of the lipids was done as described
(Pfeilschifter et al., 1984). In brief, for the separation of
neutral lipids, chromatographs were developed in one
dimension using n-heptane/diethyl ether/acetic acid
(75:25:4, by vol.) For separation of phospholipids,
chromatographs were developed in one dimension using
chloroform/methanol/acetic acid/water (100:30:35:3,
by vol.) Polyphosphoinositides were separated on thin
layer plates pretreated with 1% potassium oxalate
containing 2 mM-EDTA using chloroform/methanol/
4 M-NH4OH (9:7:2, by vol.)
Pretreated t.l.c. plates were activated for 30 min at
1 5 °C prior to addition of lipid samples. Lipid standards
were added as carriers and visualized by iodine staining.
32P-labelled lipids were additionally localized by auto-
radiography. 14C-labelled lipids were analysed with a
TLC-Linear-Analyzer LB 2821 (Berthold, Miinchen,
Germany). The detection efficiency for 14C was about 5%.
32P-labelled lipids were scraped offand counted by liquid
scintillation in water (Cerenkov counting).
Extraction and determination of inositol phosphates
After the prelabelling period the medium was removed
and the cells were rinsed several times to remove free
[3H]inositol. After this procedure cells were incubated for
various times in 1 ml of MEM with or without agents.
After the different times the medium was aspirated and
the reactions were terminated by addition of 1 ml of 15%
(w/v) trichloroacetic acid. The trichloroacetic acid was
removed with diethyl ether. The final extract was
neutralized and applied to anion-exchange columns
containing 1 ml of Dowex 1 X8 (100-200 mesh, formate
form; Serva, Heidelberg, Germany). Free inositol and the
inositol phosphates were eluted sequentially by using (a)
water (inositol), (b) 5 mM-disodium tetraborate/60 mm-
sodium formate (glycerophosphoinositol), (c) 0.1 M-
formic acid/0.2 M-ammonium formate (IP1), (d)
0.1 M-formic acid/0.4 M-ammonium formate (OP2) and (e)0.1 M-formic acid/1.0 M-ammonium formate (UP3), ex-
actly as described by Berridge (1983). The identification
of IP2 and IP3 was cross-checked by co-running of
32P-labelled IP2 and IP3 prepared as described by Downes
et al. (1982). Radioactivity was counted in Aquasol 2
(New England Nuclear) in a ,-scintillation counter.
Prostaglandin and protein analysis
Culture dishes were washed twice with L-15 medium
(Boehringer) and at the onset of the experiment 1 ml of
fresh L-15 medium with or without agents was added
followed by a 5 min incubation. The medium was then
withdrawn, frozen in liquid N2 and stored at -80 °C until
1986
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assay for prostaglandins. Verapamil was added where
indicated at a final concentration of 10-5 M 5 min prior
to the addition of the agonists. PGE2 concentrations of
the culture media were determined by radioimmunoassay
for PGE2 (New England Nuclear). Cells were dissolved
in 0.5 M-NaOH and protein was determined according to
the method of Lowry et al. (1951) with bovine serum
albumin (Sigma) as standard.
Chemicals
Lipid standards, angiotensin II, noradrenaline,
AGEPC, TPA, OAG and verapamil were obtained from
Sigma. [1-14C]Arachidonic acid, myo-[2-3H]inositol,
45CaC12 and carrier-free 32P, were purchased from
Amersham International. All other chemicals were from
Merck, Darmstadt, Germany.
RESULTS
Vasoconstrictors stimulate PGE2 synthesis in mesangial
cells
Basal and agonist-stimulated PGE2 synthesis is
summarized in Table 1. In the basal state PGE2
production was 2.0 ng/5 min per mg ofprotein. Addition
of noradrenaline (10-5 M), angiotensin II (10-v M), and
AGEPC (10-8 M) increased the rate of PGE2 production
by 93, 132 and 166% respectively. The addition of the
calcium channel blocker verapamil (10-5 M) abolished the
vasoconstrictor-induced stimulation ofPGE2 synthesis in
mesangial cells (Table 1). Verapamil blocked the
angiotensin II (10-v M)-induced PGE2 synthesis with an
IC50 value of 4 x 10-6 M. Verapamil alone had no effect
on basal PGE2 synthesis. Verapamil had also no effect on
the PGE2 synthesis evoked by the addition of exogenous
arachidonic acid (results not shown). This clearly shows
that verapamil did not interfere with cyclo-oxygenase
activity.
Table 1. Effect of verapamil on basal and vasoconstrictor-
stimulated PGE2 synthesis
Mesangial cells were incubated and PGE2 synthesis was
measured as outlined under 'Experimental procedures'.
Verapamil was added at a final concentration of 10-5 M
5 min prior to the addition of the agonists. Results are
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Table 2. Effect of verapamil on basal and vasoconstrictor-
stimulated 45Ca2+ uptake in mesangial cells
The cells were incubated and 45Ca2+ influx was measured
as outlined under 'Experimental procedures'. Verapamil
was added at a final concentration of 10-l M 5 min prior
to the addition of the agonists. Results are means + S.E.M.
for the number of experiments shown in parentheses.
45Ca2+ influx
(c.p.m./min per
Addition mg of protein)
Control 1648+106 (10)
Verapamil (10 /SM) 989+100 (10)
Noradrenaline (10 #M) 1039 + 149 (5)
+ verapamil (10 /M)
Angiotensin 11 (100 InM) 1157+ 118 (5)
+ verapamil (10 /tM)




The uptake of45Ca2+ was measured 15, 30, 60 and 120 s
after the addition of 4,Ci of 45Ca2+/ml to the cells
incubated in the presence of 2 mM-CaCl2. The basal
45Ca2+ influx as calculated from the slope of the
regression lines was 1648 + 106 c.p.m./min per mg of cell
protein. Addition of noradrenaline (10-5 M), angiotensin
II (10-7 M) and AGEPC (10-8 M) at the same time as
45Ca2+ increased the influx to 1930 + 87, 2359 + 212 and
2767 + 238 c.p.m./min per mg of cell protein (means +
S.E.M. from five to ten experiments). Table 2 shows the
effect of the calcium channel blocker verapamil (10-5 M)
on the hormone-stimulated Ca2+ influx in mesangial cells.
The stimulation of Ca2+ influx by noradrenaline,
angiotensin II and AGEPC was decreased to 63, 70 and
60% of the control value, respectively. Verapamil alone
decreased the Ca2+ uptake to 60% of the control value.
Vasoconstrictors stimulate phospholipase C in mesangial
cells
Fig. 1 shows the time course of the decrease in
radioactivity corresponding to PIP2 in response to the
three vasoconstrictive agents investigated. Angiotensin II
(10-7 M), noradrenaline (10-5 M) and AGEPC (10-8 M)
caused a rapid disappearance of 32p label in PIP2. This
response was initiated rapidly and reached maximal
values within 10 s for angiotensin II and noradrenaline
and at 20 s for AGEPC. This rapid loss of radioactivity
that occurred during the first 30 s or so of stimulation was
followed by a recovery of the PIP2 labelling towards its
initial level, followed by an increase above this value at
2min.
The data for PIP and PI are qualitatively similar to
those for PIP2 (not shown). The initial decrease of PIP,
however, was not statistically significant and PIP levels
rapidly increased above the initial values. After an initial
lag phase the radioactivity in PI showed a significant
decrease with a nadir at 20-30 s followed by a resynthesis
with an overshoot in relation to the initial values. This
appears to eliminate one possibility for the disappearance
of 32p label from PIP2, namely its conversion into PIP by
the specific phosphomonoesterase. If this reaction had
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Fig. 1. Time course of vasoconstrictor-induced PIP2 breakdown
32P,-labelled mesangial cells were stimulated with 10/uM-
noradrenaline (A), 100 nM-angiotensin II (0), 10 nM-
AGEPC (A) or vehicle. Values are expressed as percentage
of control and are the mean from five experiments; the
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Fig. 2. Time course of vasoconstrictor-induced
I'4Clarachidonic acid radioactivity in DG
120
changes in
Mesangial cells prelabelled with [14C]arachidonic acid were
stimulated with 10 /M-noradrenaline (A), 100 nm-
agiotensin 11 (0), 10 nM-AGEPC (A) or vehicle. Values
are expressed as percentage of control and are the means
of five experiments; the S.E.M. ranges from 4 to 12%.
radioactivity from PIP2 there was an increase of label in
DG. Addition of angiotensin II, noradrenaline and
AGEPC to mesangial cells prelabelled with
[14C]arachidonic acid stimulated a rapid and transient
formation of [14C]DG (Fig. 2). The maximal increase of
label in DG could be observed as early as 10 s after
addition ofthe vasoconstrictors and reaches 152%, 140%
and 164% ofcontrol levelforangiotensin II, noradrenaline
and AGEPC, respectively. Thereafter the values for 14C
radioactivity in DG decreased towards control levels.
Stimulation of mesangial cells with angiotensin II,
noradrenaline and AGEPC also resulted in significant
increases in the levels of IP1, IP2 and IP3 as early as 10 s
after the addition of the agonists, as shown in Table 3.
Simultaneous addition of verapamil and noradrenaline
did not alter the rate of activation nor the time course of
activation of phospholipase C. Table 4 shows that
verapamil had no effect on the degradation of PIP2 and
the production of DG and IP3 caused by the addition of
noradrenaline. Verapamil alone did not alter the levels of
PIP2, DG and IP3 in mesangial cells at the time point
examined.
Table 3. Effect of vasoconstrictors on inositol phosphate
accumulation in mesangial cells
Cultured mesangial cells were prelabelled with myo-[2-
3H]inositol for 72 h as described under 'Experimental
procedures'. The cells were then stimulated for 10 s with
10 ,M-noradrenaline, 100 nm-angiotensin II and 10 nM-
AGEPC. Values are expressed as means + S.E.M. obtained
from five independent experiments.
[3H]radioactivity
(c.p.m./mg of protein) in:
Addition IP1 1P2 1P3
Control 393 + 37 113+22 75 + 10
Noradrenaline 962+64 352+38 141+17
Angiotensin II 1061+72 395+52 163+15
AGEPC 1084+ 104 384+63 175+22
Table 4. Effect of verapamil on noradrenaline-induced activation
of phospholipase C
taken place it would have led to a rapid increase in PIP
labelling, i.e. to the opposite of the observed results. The
decrease in PI labelling is probably due to the increased
resynthesis ofPIP and PIP2. However, we cannot rule out
the possibility that phospholipase C also directly cleaves
PI. The increase in PI labelling after 1 min is not easy
to reconcile with a resynthesis of polyphosphoinositides
from PI. In this instance one would expect a further
decrease but not an increase of PI. One can speculate that
there are different pools of PI, one of which is more
readily available for resynthesis than the other. We have
ascertained in independent experiments that the PI pool
was in isotopic equilibrium. However some small pools
of PI may have been below the detection level and these
poolscould have been the source for polyphosphoinositide
resynthesis.
Simultaneously with the disappearance of 32p_
Mesangial cells were prelabelled with 32p1, [14Clarachidonic
acid or myo-[2-3H]inositol respectively, as described under
'Experimental procedures'. The cells were then stimulated
for 1O s with 10 M-noradrenaline, 10 M-noradrenaline
plus 10 /SM-verapamil or vehicle. Radioactivity in PIP2, DG
and 1P3 respectively was determined as outlined under
'Experimental procedures'. Values are the means of five
experiments+ S.E.M.
Radioactivity
(c.p.m./mg of protein) in:
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which was also observed with angiotensin II, nor-
adrenaline and AGEPC. In further analogy with the
vasoconstrictive hormones, the effects of TPA and OAG
on calcium uptake and PG synthesis could be inhibited
by verapamil (10-5 M). Chelation of calcium with EDTA
also inhibited TPA- and OAG-stimulated PGE2 synthesis.
The non-tumour-promoting 4a-phorbol 12,1 3-dideca-
noate at a concentration of 10-7 M did not increase PGE2
synthesis nor 45Ca2+ uptake in mesangial cells. TPA itself
up to concentration of 10-7 M did not alter the levels of
the inositol phosphates or DG during the first 2 min
after its addition to mesangial cells.
0 10-l 10-9 10-8 10-7 10-6 105 10o
[TPA] (M) [OAG] (M)
Fig. 3. Dose-response curve to TPA and OAG for PGE2
synthesis in mesangial cells
The effect of TPA (0, *) and OAG (A, A) on PGE2
synthesis in mesangial cells is shown; *, A, the effect of
10 /SM-verapamil on this stimulated PGE2 synthesis. Values










Fig. 4. Dose-response curve to TPA and OAG for initial uptake
of 46Ca2+ into mesangial cells
The effect of TPA (0, 0) and OAG (A., ) on initial
uptake of 45Ca2+ into mesangial cells is shown; *, A, the
effect of 10, 4M-verapamil on this stimulated 45Ca2+ uptake.
Values are the mean of seven experiments+ S.E.M.
Effect of phorbol esters and OAG on PGE2 synthesis and
45Ca2+ uptake in mesangial cells
Noradrenaline, angiotensin II as well as AGEPC
increase the concentration of DG in mesangial cells. We
therefore wanted to test whether the activation of protein
kinase C by DG would be a common mechanism by
which vasoconstrictors enhance calcium permeability of
the cell membrane and provoke PG synthesis in
mesangial cells. Like DG, TPA is also known to increase
greatly the affinity of protein kinase C for calcium,
thereby leading to an activation of the enzyme
(Kishimoto et al., 1980). We therefore examined the
influence of the phorbol esters TPA and 4a-phorbol 12,
13-didecanoate as well as the synthetic DG analogue
OAG on PG synthesis and 45Ca2+ uptake. Figs. 3 and 4
show that TPA and OAG increased PG synthesis and
enhanced 45Ca2+ uptake in a dose-dependent manner
DISCUSSION
It was the aim of the present study to obtain
information on the possibility of a common mechanism
by which the vasoconstrictors angiotensin II, nor-
adrenaline and AGEPC increase PG synthesis in renal
mesangial cells. All three vasoconstrictors significantly
enhanced PG production (Table 1) and 45Ca2+ uptake by
mesangial cells. Both effects could be abolished by the
calcium channel blocker verapamil (Tables 1 and 2). Since
calcium influx into cells is thought to be limited by the
availability of open calcium channels in the plasma
membrane, the question arises as to which mechanism
angiotensin II, noradrenaline and AGEPC stimulate
calcium influx, thereby increasing PG synthesis. In
general, hormones that mediate physiological responses
through calcium mobilization also stimulate the metab-
olism of membrane phosphoinositides (cf. Michell et al.,
1981; Michell, 1982). This was also found to be true of
angiotensin II, noradrenaline and AGEPC in cultured
mesangial cells. The results presented in Figs. 1 and 2 and
in Table 3 clearly indicate that these vasoconstrictors
caused an activation of phospholipase C, which led to an
increased formation oftwo important second messengers,
IP3 and DG. There is growing evidence that DG and IP3
synergistically mediate signal transduction in receptor
systems linked to calcium mobilization (cf. Berridge,
1984). IP3 is thought to be the intracellular signal to
promote hormone-induced calcium mobilization (cf.
Berridge & Irvine, 1984) and DG activitates protein
kinase C which in turn phosphorylates various cellular
proteins (cf. Nishizuka, 1984). In mesangial cells it seems
that the calcium released by 1P3 is either not sufficient to
increase PG formation over basal values, or is being
sequestered intracellularly in such a way that it has no
access to Ca2+-regulated phospholipases which cleave off
arachidonate. This can be inferred from the finding that
verapamil inhibited vasoconstrictor-induced influx of
45Ca2+ on PG synthesis but had no effect whatsoever on
the formation of IP3 (Table 4). Theoretically it is possible
that verapamil not only inhibits Ca2+ entry across the
plasma membrane but also IP3-induced Ca2+ release from
intracellular stores. The available experimental evidence,
however, argues against this latter possibility (Biden
et al., 1984).
The increase of the Ca2+ permeability of the plasma
membrane upon challenging mesangial cells with vaso-
constrictive hormones is likely to be related to a
stimulation of protein kinase C by DG. This contention
receives experimental support from the finding that TPA
and OAG enhanced PG synthesis and 46Ca2+ entry in a
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be blocked by verapamil or,by omission of extracellular
calcium (Figs. 3 and 4). TPA and OAG are potent
activators of protein kinase C (Castagna et al., 1982;
Nishizuka, 1983) which are widely used to by-pass
hormone-induced alterations of the phosphoinositide
metabolism ofthe cell membrane. In contrast, 4a-phorbol
12,13-didecanoate, a phorbol ester which does not
stimulate protein kinase C (Nishizuka, 1984), had no
effect whatsoever on either Ca2+ entry or PG synthesis.
This result renders an unspecific effect of OAG and
TPA on the cell metabolism unlikely and further supports
the role of protein kinase C in regulating the Ca2+
permeability of the plasma membrane of renal mesangial
cells.
It is noteworthy in this connection that TPA stimulates
PG synthesis in different tissues (Levine & Hassid, 1977;
Butler-Gralla et al., 1983; Snoek & Levine, 1983; Kucera
et al., 1984) including cultured MDCK cells. The
TPA-induced synthesis in MDCK cells was attributed to
an activation of phospholipase A2 (Daniel et al., 1981;
Beaudry et al., 1983) which is known to be activated by
Ca2+. Our results on the regulation of Ca2+ permeability
by protein kinase C offer an explanation for the results
obtained in MDCK cells. In view of the fact that
-mesangial cells are the contractile elements of the renal
glomeruli (Scharschmidt & Dunn, 1983; Fujiwara et al.,
1984) it is particularly interesting that Rasmussen et al.
(1984) and Danthuluri & Deth (1984) were able to
produce Ca2+-dependent contraction of arterial vessel
preparations with TPA.
These results, taken together with the observations
reported in the present study, point towards a more
general role of DG-mediated activation of protein kinase
C in the recruitment of extracellular calcium. Exactly by
which mechanisms this physiological regulation is being
effected is unknown. In analogy with cyclic AMP-
dependent protein kinases (Kandel & Schwartz, 1982;
Nestler & Greengard, 1983), the phosphorylation ofparts
of a calcium channel could be a possibility for the mode
of action of the protein kinase C as well.
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